Health Condition 1: B081- Molluscum contagiosum
Conditions
Interventions
Intervention1: Individualized Homoeopathic medicine: Individualized homoeopathic remedies in centesimal potencies and appropriate doses will be prescribed for oral administration based on symptom simi
Sponsors
Central Council for Research in Homoeopathy, New Delhi, Ministry of AYUSH, Government of India
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients having age between 2-25years. 2.Patients of both sexes. 3.Patients presenting with characteristic features of molluscum including firm, pearly, dome-shaped papules with central umbilication (pit); pink or skin colored lesions which may be symptomatic or asymptomatic. These lesions can be itchy or painful and may appear individually or in groups. 4.Having at least three lesions of molluscum 5.Participant is willing to participate in the study and give written consent/assent for the study
Exclusion criteria
Exclusion criteria: 1.Patients on conventional treatment or other systems of medicine for the symptoms of molluscum contagiosum. 2.Immunocompromised patients. 3.Pregnant or breastfeeding females. 4.Patients with significant injury on and/or surrounding MC that may impact ability to treat and count lesions 5.Molluscum associated with active cases of atopic dermatitis 6.Patients suggestive of sexually transmitted molluscum contagiosum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Changes in cases of molluscum using Investigator and Subject Global Severity Assessment, Investigator and Subject Global Impression of Change score. 2. Changes in BOTE score of inflammationTimepoint: 1.From baseline, fortnightly till 12 weeks (end of treatment). 2.From baseline, fortnightly till 12 weeks (end of treatment). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Changes in overall life quality of cases of molluscum using CDLQI in children and DLQI in adults 2.Changes in number of molluscum lesion Timepoint: 1.From baseline, every month of treatment till the end of the treatment. (3rd month) 2.From baseline, fortnightly till 12 weeks (end of treatment) | — |
Countries
India
Contacts
Public ContactDr Renu Mittal
Central Council for Research in Homoeopathy
Outcome results
None listed